Summary: A retrospective study of 25 patients treated for primary gastric lymphoma was made to investigate a number of problems related to treatments and report the factors influencing prognosis. In the 5-year-survival rate according to Working Formulation classification, either survival rate of low-grade type or intermediate-grade type was higher than that of high-grade type. Both the 5-yearsurvival rate of cases without lymph node metastasis and that of cases that involved perigastric lymph nodes were higher than that of cases that involved distant gastric lymph nodes. Those surviving five years after perigastric lymph node metastasis had received D3 or D4 dissection and postoperative multicombined chemotherapy. Tumors invading only to the submucosal layer had received D2 dissection and were not treated by postoperative multicombined chemotherapy, and recurrence was not recognized in these cases. Of 9 cases infiltrating into the musclaris propria or serosa without lymph node metastasis, 8 cases were treated by postoperative multicombined chemotherapy and were alive without recurrence, but one case without postoperative multicom bined chemotherapy died by recurrence. Therefore, adequate therapy for gastric lymphoma with infiltrating into submucosal layer is gastrectomy with D2 lymph node dissection, and postoperative multicombined chemotherapy is not necessary. The cases with perigastric lymph node metastasis, or the cases with invading from muscularis propria to serosa require D3 or D4 lymph node dissection with postoperative multicombined chemotherapy. But the cases with distant gastric lymph node metastasis or invading adjacent structure or high-grade type histologically (WF classification) require preoperative chemotherapy.
INTRODUCTION
Primary gastric lymphoma comprises 1.0 to 5.0% of all cases of gastric malignant tumor [1, 2] . Surgical resection is usually selected as the treatment of choice for primary gastric lymphoma, as in cases of primary gastric carcinoma.
But a good effect from multicombined chemotherapy has been reported for primary gastric lymphoma [3] [4] [5] . The treatment for gastric lymphoma is now different from that for gastric carcinoma and may include surgical resection with or without multicombined chemotherapy. The individual roles of each of these modalities of therapy are, however, often debated. There is much disagreement and controversy regarding the efficacy of surgical resection alone, the optimal extent of resection, and the contribution to curative value of multicombined chemotherapy.
Here we have undertaken a retrospective clinicopathological evaluation and investigated a number of problems related to treatment, and report the factors influencing prognosis. Patients 
MATERIALS AND METHODS
In the 15 years between 1980 and 1994, 25 cases of primary gastric lymphoma were surgically resected at our hospital. This corresponds to 1.3% of the total of 1,915 cases of gastric malignant tumor that were resected during this same period. Twelve patients were men and 13 were women. The mean age was 59.6 years, with age range from 26 to 89 years. For this study, histopathological examinations were undertaken according to the Working Formulation classification (WF classification). Tumors were staged according to the classification of The General Rules for Gastric Cancer Study in Surgery and Pathology [6] . Sands classification was used for the gross appearance of the tumor. were considered significant at the 5% level.
RESULTS
All cases were non-Hodgkin's or B cell lymphoma. There are 29 lesions in these cases; the ulcerative type was the most common, accounting for 13 lesions (52%), the superficial type accounted for 9 lesions (36%), the protruded type for 1 lesion (4%), (Table 1) . Fourteen lesions occurred mainly in the M region, 7 lesions occurred mainly in the C region, and 8 lesions occurred mainly in the A region (Table 2) . Two cases had 2 lesions each, one case had 3 lesions, and 22 cases had single lesions each. In 22 lesions, 11 lesions were localized to one region, 7 lesions localized to two regions, and 4 lesions localized to the entire region. Total gastrectomy was performed in 15 cases, distal gastrectomy was performed in 9 cases, and proximal gastrectomy was performed in one case (Table 2. .
No case was limited to the mucosal layer, but there were 5 cases with early lesions infiltrating into the submucosa, 4 cases with infiltrating into the muscularis propria layer, 2 cases with infiltrating into the subserosa, 11 cases with infiltrating into exposed serosa, and 3 cases with infiltrating into an adjacent structure (Table 3) .
Of the cases infiltrating into the submucosal layer, 5 cases received D2 dissection, and only one case was treated by postoperative chemotherapy, and all are alive without recurrence for longer than 3 years to date (Table 4) . Of the cases infiltrating into the muscularis propria layer, 4 cases received D3 dissection with postoperative chemotherapy, and all are alive without recurrence for longer than 3 years to date. A further 2 cases received D2 dissection without postoperative chemotherapy and one of these two died by recurrence at 47 months and the other died by lung cancer at 16 months (Table 4) . Of the cases infiltrating into the subserosa, 2 cases received D2 or D3 dissection with postoperative chemotherapy and all are alive without recurrence for longer than 3 years to date (Table 4) . Of the cases infiltrating into exposed serosa, 6 cases received D3 or D4 disection with postoperative chemotherapy, and 3 of these are alive without recurrence for longer than 3 years to date. Another 4 cases received D3 or D4 dissection without postoperative chemotherapy and 2 of these 4 are alive without recurrence for longer than 3 years to date, and one other case received D2 dissection without postoperative chemotherapy, and is alive without recurrence for longer than 3 years to date. All 3 cases invading an adjacent structure received combined resection; one case received no lymph node dissection and no postoperative chemotherapy, one case received D3 dissection without postoperative chemotherapy, and the other case received D4 dissection with postoperative chemotherapy; all these 3 cases died by recurrence within 16 AOYAGI ET AL. months after the operation (Table 4) . Twelve of 16 cases which had no lymph node metastasis are alive without recurrence for longer than 3 years (Table 5) . One case that involved nl lymph node . without postoperative chemotherapy died by recurrence at 47 months after operation ( Table 5 ). Three of 5 cases which involved n2 lymph node metastasis received D3 dissection with postoperative chemotherapy and are alive without reurrence for longer than 3 years (Table 5 ). All 3 cases that extended to n3 metastasis died within 18 months after the operation (Table 5 ).
The 5-year-survival rate of cases infiltrating into the submucosal layer was 100%, that of cases infiltrating into the muscularis propria or subserosa was 75%. That of cases infiltrating into the exposed serosa was 55%, and that of cases infiltrating into an adjacent structure was 0%. The 5-year-survival rate according to macroscopic type was 100% for superficial type, 51% for ulcerative type, and 50% for excavated type. The survival rate for superficial type was higher than that for ulcerative type, and higher than that for excavated type (Fig. 4) . In cases infiltrating into the muscularis propria or deeper, the 5-year-survival rate of cases with postoperative chemotherapy was 64%, and of cases without postoperative chemotherapy was 37% (Fig. 6 ).
In cases with lymph node metastasis, the 5-yearsurvival rate of cases with postoperative chemotherapy was 50% and of cases without postoperative chemotherapy was 0% (Fig. 7) . 
DISCUSSION
Of all extranodal lymphomas, primary gastric lymphoma is clearly the most common and accounts for over one half of all gastrointestinal tumors [7] . Yet little is known about the biology and management of a primary gastric lymphoma. Takeshita et al. [8] recommended performing adequate resection of lymph nodes in primary gastric lymphoma, as in gastric carcinoma, and administering appropriate combination chemotherapy, and then postoperative long-term results were similar to, or better than, AOYAGI ET AL.
those obtained with gastric carcinoma. It is said that curative resection with extensive lymph node dissection is in the proper treatment for primary gastric lymphoma [9, 10] , but alone is insufficient for advanced cases, in which postoperative chemotherapy should be applied in combination [11] . Here we discuss the adequate therapy for a primary gastric lymphoma, and decide on surgery alone or in combination with chemotherapy.
There were no lymph node metastatic cases in 5 cases with infiltrating into the submucosal layer. These 5 cases received D2 dissection, and only one case was treated by postoperative chemotherapy, but their 5-year-survival rate was 100%. So adequate therapy for gastric lymphoma with infiltrating into submucosal layer is gastrectomy with D2 lymph node dissection, and postoperative multicombined chemotherapy is not necessary. Of the mp and ss cases, 6 cases received D3 or D2 dissection with postoperative chemotherapy and all 6 cases are alive without recurrence for longer than 3 years. However, another 2 cases received D2 dissection without postoperative chemotherapy, and one of these 2 cases died by recurrence at 47 months and the other died by lung cancer at 16 months. Of these cases, 6 cases received D3 or D4 dissection with postoperative chemotherapy, but 3 cases died by recurrence within 3 years, with 2 of these 3 cases of high-grade type histologically and the other n3. Another 4 cases received D3 or D4 dissection without postoperative chemotherapy, and 2 of these 4 cases died due to recurrence within 3 years, with these 2 cases of highgrade type histologically. One case received D2 dissection without postoperative chemotherapy and is alive without recurrence and this case was n0. All three cases that invaded an adjacent structure died by recurrence within 16 months after the operation. The prognosis of n0 cases was good but cases deeper than mp cases require postoperative chemotherapy. Of the nl and n2 cases, if the case received D3 or D4 dissection with postoperative chemotherapy, then the case is alive without recurrence for longer than three years except high-grade type cases histologically. All the 3 cases that extended to group 3 lymph node metastasis died within 18 months after the operation.
The Working Formulation classification is a major predictive factor. Orlando et al. [12] reported that the Working Formulation was more useful than the Rappaport classification for assessing prognosis in various types of lymphoma and better reflected our current understanding of neoplasmas in the lymphoid system. Regarding the 5-year-survival rate according to histological type (WF classification), low-grade type was 100%, while high-grade type was 0%. Factors influencing prognosis are considered to be gross type, depth of invasion, lymph node involvement, tumor size and histological type. In our study, the PCNA LI was a good marker for prognosis of malignant lymphoma and statistically significant favorable prognostic variables were a lower PCNA LI (<30%), superficial mural invasion (submucosal only), without lymph node metastasis, and clinicopathologicall stage I disease; these variables were strongly significant.
